Citadel Advisors
STIM icon

Citadel Advisors’s Neuronetics STIM Stock Holding History

Citadel Advisors’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$548K Buy
421,903
+345,306
+451% +$502K ﹤0.01% 9624
2026
Q1 		$111K Buy
+76,597
New +$121K ﹤0.01% 11917
2025
Q2 		– Sell
-70,007
Closed -$276K – 14974
2025
Q1 		$258K Buy
+70,007
New +$256K ﹤0.01% 9922
2024
Q3 		– Sell
-104,173
Closed -$137K – 15205
2024
Q2 		$188K Buy
104,173
+12,764
+14% +$36.8K ﹤0.01% 10036
2024
Q1 		$435K Buy
91,409
+9,458
+12% +$33.2K ﹤0.01% 8690
2023
Q4 		$238K Sell
81,951
-110,625
-57% -$174K ﹤0.01% 9613
2023
Q3 		$260K Sell
192,576
-48,507
-20% -$85K ﹤0.01% 9425
2023
Q2 		$518K Buy
241,083
+77,492
+47% +$188K ﹤0.01% 7857
2023
Q1 		$476K Buy
163,591
+156,944
+2,361% +$791K ﹤0.01% 8424
2022
Q4 		$45.7K Sell
6,647
-29,108
-81% -$137K ﹤0.01% 12247
2022
Q3 		$113K Sell
35,755
-61,418
-63% -$223K ﹤0.01% 10989
2022
Q2 		$312K Buy
97,173
+44,514
+85% +$129K ﹤0.01% 9719
2022
Q1 		$160K Buy
+52,659
New +$178K ﹤0.01% 11782
2021
Q4 		– Sell
-12,693
Closed -$83K – 14721
2021
Q3 		$83K Sell
12,693
-31,293
-71% -$300K ﹤0.01% 13045
2021
Q2 		$704K Sell
43,986
-39,499
-47% -$546K ﹤0.01% 9235
2021
Q1 		$1.03M Buy
83,485
+65,579
+366% +$1.01M ﹤0.01% 8033
2020
Q4 		$199K Sell
17,906
-2,663
-13% -$20K ﹤0.01% 9735
2020
Q3 		$100K Buy
+20,569
New +$78K ﹤0.01% 9277
2020
Q1 		– Sell
-21,338
Closed -$96K – 10149
2019
Q4 		$96K Buy
21,338
+5,752
+37% +$35.7K ﹤0.01% 8566
2019
Q3 		$129K Buy
15,586
+2,372
+18% +$25.9K ﹤0.01% 8366
2019
Q2 		$165K Sell
13,214
-9,249
-41% -$131K ﹤0.01% 8312
2019
Q1 		$342K Buy
22,463
+10,456
+87% +$173K ﹤0.01% 7414
2018
Q4 		$232K Buy
12,007
+1,238
+11% +$27.2K ﹤0.01% 7656
2018
Q3 		$345K Sell
10,769
-1,976
-16% -$60.1K ﹤0.01% 7345
2018
Q2 		$339K Buy
+12,745
New +$347K ﹤0.01% 7009

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors's STIM Position: Q2 2026 in Review

Citadel Advisors increased its Neuronetics (STIM) stake by 451% in Q2 2026, buying an estimated $502K and bringing the position to 421,903 shares worth $548K. The position accounts for ﹤0.01% of the portfolio, ranked #9624.

Citadel Advisors first reported a position in STIM in Q2 2018 and has held it in 25 quarters since. The position peaked at $1.03M in Q1 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Citadel Advisors held 421,903 shares of Neuronetics worth $548K as of Q2 2026.
  • Citadel Advisors bought 345,306 Neuronetics shares in Q2 2026, an estimated $502K.
  • Neuronetics made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #9624 holding.
  • Citadel Advisors first reported a position in Neuronetics in Q2 2018 and has held it in 25 quarters since.
  • Citadel Advisors's Neuronetics position peaked at $1.03M in Q1 2021.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.